M. Basso

Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.

M. Pelizzo, F. Vianello, C. Mian, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.

A. Haug, P. Bartenstein, F. Vianello, 2014, Thyroid : official journal of the American Thyroid Association.

Follicular thyroid carcinoma with metastases to the pituitary causing pituitary insufficiency.

F. Vianello, C. Mian, R. Mazzarotto, 2011, Thyroid : official journal of the American Thyroid Association.

The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study

Luigi Corti, Simone Mocellin, Sara Valpione, 2012, Breast Cancer Research and Treatment.

Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients

Antonella Vecchiato, Luigi Corti, Simone Mocellin, 2008, Annals of Surgical Oncology.

Clinical electrochemotherapy for chest wall recurrence from breast cancer

E. Sieni, F. Dughiero, L. Campana, 2014 .

A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA.

F. Vianello, L. Boldrini, N. Dinapoli, 2018, European journal of internal medicine.

External Beam Radiotherapy in Thyroid Carcinoma: Clinical Review and Recommendations of the AIRO “Radioterapia Metabolica” Group

F. Vianello, E. Russi, M. Mangoni, 2017, Tumori.